Meloxicam can help with gout flares, but it’s not the first choice most doctors reach for. It’s included in clinical guidelines as one of several NSAIDs that treat acute gout, typically at 15 mg daily. However, it’s not FDA-approved specifically for gout, and its slower onset of action makes faster-acting alternatives more popular when you’re in the middle of a painful attack.
What Guidelines Say About Meloxicam for Gout
The American College of Rheumatology and European Alliance of Associations for Rheumatology both recommend NSAIDs as a first-line treatment for acute gout flares. Within that class, naproxen and indomethacin are the preferred options. Meloxicam appears on the list of alternatives alongside ibuprofen, diclofenac, and celecoxib.
The distinction matters. Naproxen and indomethacin are specifically studied and dosed for gout attacks. Meloxicam is FDA-approved only for osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis. When a doctor prescribes it for gout, that’s considered off-label use. It’s a common and accepted practice, but it means the drug wasn’t tested in clinical trials designed around gout flares.
Why It’s Not the Top Pick for Acute Flares
Gout attacks are famously intense. The joint, often the big toe, can go from normal to agonizingly swollen in a matter of hours. In that situation, you want relief as fast as possible. Meloxicam has a longer half-life and takes longer to build up to its full effect compared to naproxen or indomethacin, which hit harder and faster. For a condition where every hour of pain matters, that slower ramp-up is a real disadvantage.
Naproxen, for example, is typically dosed at 500 mg twice daily for gout flares, providing strong anti-inflammatory coverage quickly. Indomethacin at 50 mg three times daily is another aggressive option. Meloxicam’s standard gout dose of 15 mg once daily reflects its longer-acting design, which is ideal for chronic conditions like osteoarthritis but less suited to the acute, explosive nature of a gout attack.
Where Meloxicam Has an Advantage
If you’ve had stomach problems with other anti-inflammatory drugs, meloxicam may be worth considering. A meta-analysis published in The American Journal of Medicine found that patients taking meloxicam had roughly 36% fewer gastrointestinal side effects compared to traditional NSAIDs. They also experienced less frequent indigestion (27% lower odds) and about half the rate of serious complications like stomach ulcers or gastrointestinal bleeding. Patients on meloxicam were also 41% less likely to stop taking the drug because of stomach-related problems.
This gentler stomach profile exists because meloxicam is more selective for a specific type of inflammation enzyme, sparing the protective lining of the stomach to a greater degree than drugs like naproxen or indomethacin. For someone who needs an NSAID for gout but has a history of ulcers, acid reflux, or GI sensitivity, that trade-off between slightly slower relief and better tolerability could be worthwhile.
Kidney Concerns for Gout Patients
Gout and kidney problems frequently go hand in hand. High uric acid levels, the root cause of gout, can damage the kidneys over time, and reduced kidney function makes it harder to clear uric acid from the body. This creates a real challenge when choosing a treatment, because all NSAIDs, meloxicam included, can strain the kidneys.
Meloxicam is not recommended for anyone with severe kidney disease. Warning signs of kidney trouble while taking it include decreased urination, swelling in the face, fingers, or lower legs, unusual fatigue, and unexplained weight gain. Older adults face higher risk for these complications and may need a lower dose or a different treatment approach entirely. If you have any degree of kidney impairment, your doctor may steer away from NSAIDs altogether and use colchicine or corticosteroids instead.
When Meloxicam Makes Sense for Gout
Meloxicam fits best in a few specific scenarios. If you’re already taking it for another condition like osteoarthritis and develop a gout flare, it may provide some relief without adding a second medication. It’s also a reasonable option when faster-acting NSAIDs have caused stomach problems in the past, or when the flare is mild to moderate rather than severe.
For a full-blown, first-time gout attack with extreme swelling and pain, most treatment guidelines point you toward naproxen, indomethacin, colchicine, or corticosteroids first. These options deliver faster, more targeted relief. Meloxicam works through the same anti-inflammatory mechanism as other NSAIDs, so it will reduce pain and swelling, but it gets there more slowly.
It Won’t Prevent Future Attacks
No NSAID, meloxicam or otherwise, addresses the underlying cause of gout. These drugs reduce inflammation during a flare but do nothing to lower uric acid levels. If you’re having repeated gout attacks, the long-term solution involves urate-lowering therapy, dietary changes, and managing risk factors like alcohol intake and dehydration. Meloxicam is a tool for managing symptoms during a flare, not a strategy for preventing the next one.